UCB SA (UCBJF)

CTI BioPharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	40,551	37,751	16,546	14,934	21,548	19,525
Market Cap Growth	32.13%	128.16%	10.80%	-30.70%	10.36%	30.28%
Enterprise Value	42,013	40,454	19,242	17,608	23,270	21,861
Last Close Price	213.80	194.96	86.19	79.56	106.83	105.19
PE Ratio	25.92	34.24	43.64	33.43	17.91	21.81
PS Ratio	5.04	5.93	2.89	2.57	3.28	2.99
PB Ratio	3.57	3.64	1.67	1.54	2.26	2.19
P/TBV Ratio	31.77	75.18	-	-	350.88	-
P/FCF Ratio	25.77	36.17	28.62	16.12	14.91	19.35
P/OCF Ratio	21.91	29.36	19.67	12.49	12.20	14.77
EV/Sales Ratio	5.31	6.35	3.36	3.03	3.54	3.34
EV/EBITDA Ratio	19.57	26.24	13.72	14.48	12.84	13.32
EV/EBIT Ratio	29.92	46.08	30.12	27.51	15.57	17.25
EV/FCF Ratio	26.70	38.76	33.28	19.00	16.10	21.66
Debt / Equity Ratio	0.30	0.30	0.34	0.32	0.25	0.38
Debt / EBITDA Ratio	1.55	2.03	2.39	2.45	1.30	1.98
Debt / FCF Ratio	2.15	3.00	5.81	3.35	1.67	3.33
Asset Turnover	0.42	0.37	0.33	0.36	0.42	0.44
Inventory Turnover	1.46	1.50	1.76	1.88	1.66	1.67
Quick Ratio	1.00	0.87	0.79	0.62	0.87	0.82
Current Ratio	1.35	1.36	1.32	1.06	1.31	1.27
Return on Equity (ROE)	14.29%	11.21%	3.80%	4.81%	13.48%	10.66%
Return on Assets (ROA)	4.63%	3.22%	2.30%	2.49%	5.97%	5.31%
Return on Capital (ROIC)	6.19%	4.23%	3.01%	3.33%	8.00%	7.07%
Return on Capital Employed (ROCE)	9.20%	6.10%	4.50%	4.70%	11.50%	9.90%
Earnings Yield	3.86%	2.92%	2.29%	2.99%	5.58%	4.59%
FCF Yield	3.88%	2.76%	3.49%	6.21%	6.71%	5.17%
Dividend Yield	0.74%	0.74%	1.74%	1.79%	1.38%	1.48%
Payout Ratio	19.82%	24.32%	73.47%	59.09%	22.68%	32.10%
Buyback Yield / Dilution	1.10%	0.33%	-0.18%	-0.34%	0.03%	-0.67%
Total Shareholder Return	1.84%	1.07%	1.56%	1.45%	1.42%	0.81%

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.